{
    "ticker": "DTIL",
    "name": "Precision BioSciences, Inc.",
    "description": "Precision BioSciences, Inc. is a biotechnology company focused on developing innovative gene-editing technologies to improve the lives of patients with serious diseases. Founded in 2006, the company is headquartered in Durham, North Carolina. Precision BioSciences utilizes its proprietary ARCUS genome editing platform, which offers a unique approach to gene editing, enabling precise modifications of DNA in various organisms. This technology is aimed at addressing genetic diseases, cancer, and infectious diseases, and has potential applications in agriculture as well. The company is committed to advancing its pipeline of therapies, including its lead product candidate, which targets hematological malignancies. Precision BioSciences is dedicated to ethical practices and transparency, ensuring that its technologies are used to benefit humanity. With a strong focus on research and development, the company collaborates with leading academic institutions and industry partners to drive innovation and bring transformative therapies to market.",
    "industry": [
        "Biotechnology",
        "Gene Editing"
    ],
    "headquarters": "Durham, North Carolina, USA",
    "founded": "2006",
    "website": "https://www.precisionbiosciences.com",
    "ceo": "Matthew Kane",
    "social_media": {
        "twitter": "https://twitter.com/PrecisionBio",
        "linkedin": "https://www.linkedin.com/company/precision-biosciences/"
    },
    "investor_relations": "https://investors.precisionbiosciences.com",
    "key_executives": [
        {
            "name": "Matthew Kane",
            "position": "CEO"
        },
        {
            "name": "Daniel O'Connor",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Gene Editing Therapies",
            "products": [
                "PBCAR0191",
                "PBCAR0231"
            ]
        },
        {
            "category": "Research Tools",
            "products": [
                "ARCUS Genome Editing Platform"
            ]
        }
    ],
    "seo": {
        "meta_title": "Precision BioSciences, Inc. | Innovative Gene Editing Technologies",
        "meta_description": "Explore Precision BioSciences, Inc., a leader in gene editing technologies committed to developing transformative therapies for genetic diseases and cancer.",
        "keywords": [
            "Precision BioSciences",
            "Gene Editing",
            "Biotechnology",
            "ARCUS",
            "Cancer Therapy",
            "Genetic Diseases"
        ]
    },
    "faq": [
        {
            "question": "What is Precision BioSciences known for?",
            "answer": "Precision BioSciences is known for its innovative gene editing technology and developing therapies for genetic diseases and cancer."
        },
        {
            "question": "Who is the CEO of Precision BioSciences?",
            "answer": "Matthew Kane is the CEO of Precision BioSciences, Inc."
        },
        {
            "question": "Where is Precision BioSciences headquartered?",
            "answer": "Precision BioSciences is headquartered in Durham, North Carolina, USA."
        },
        {
            "question": "What are Precision BioSciences' main products?",
            "answer": "Precision BioSciences' main products include PBCAR0191, PBCAR0231, and the ARCUS genome editing platform."
        },
        {
            "question": "When was Precision BioSciences founded?",
            "answer": "Precision BioSciences was founded in 2006."
        }
    ],
    "competitors": [
        "CRSP",
        "EDIT",
        "SGMO",
        "NTLA"
    ],
    "related_stocks": [
        "AMGN",
        "REGN",
        "BMY",
        "GILD"
    ]
}